Ionis to present at upcoming investor conferences

Rhea-AI Summary

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced its upcoming presentations at three investor conferences. These include the Cowen 43rd Annual Health Care Conference on March 7, 2023, the Oppenheimer 33rd Annual Virtual Healthcare Conference on March 15, 2023, and the Stifel 2023 Virtual CNS Days on March 29, 2023. Investors can access a live webcast during the events via the Investors & Media section on the Ionis website, with replays available shortly after. Ionis has been a pioneer in RNA-targeted therapy for over 30 years, focusing on innovative genetic medicine therapies.

CARLSBAD, Calif., Feb. 28, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present at the following investor conferences:

• Cowen 43^rd Annual Health Care Conference on Tuesday, March 7, 2023
• Oppenheimer 33^rd Annual Virtual Healthcare Conference on Wednesday, March 15, 2023
• Stifel 2023 Virtual CNS Days on Wednesday, March 29, 2023

A live webcast of the presentations can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. The replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.

To learn more about Ionis, visit www.ionispharma.com and follow us on Twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301757230.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals presenting at the Cowen Health Care Conference?

Ionis Pharmaceuticals will present at the Cowen 43rd Annual Health Care Conference on March 7, 2023.

What is the date for Ionis Pharmaceuticals' presentation at the Oppenheimer Virtual Healthcare Conference?

Ionis will present at the Oppenheimer 33rd Annual Virtual Healthcare Conference on March 15, 2023.

When does Ionis Pharmaceuticals participate in the Stifel Virtual CNS Days?

Ionis Pharmaceuticals will participate in the Stifel 2023 Virtual CNS Days on March 29, 2023.

How can I access the live webcast of Ionis Pharmaceuticals' presentations?

The live webcast of Ionis Pharmaceuticals' presentations can be accessed on the Investors & Media section of their website.

What innovation focus does Ionis Pharmaceuticals have?

Ionis Pharmaceuticals focuses on RNA-targeted therapy and aims to lead in genetic medicine.